منابع مشابه
Sarcopenia Sarcopenia
Sarcopenia, the loss of muscle mass and function with age, is highly relevant to clinical practice as it has been associated with a wide range of ageing outcomes including disability and shorter survival times. As such it is now a major focus for research and drug discovery. There has been recent progress in the development of consensus definitions for the diagnosis of sarcopenia, taking the fo...
متن کاملSarcopenia and planning to management: review article
Life expectancy has increased throughout the world and, as a result, the population of the elderly is also rising. From the age of 30 years old, the human body mass loses about 0.1 to 0.5% of its skeletal muscle mass annually, which is accelerated after the age of 65 years old. Aging is characterized by a decrease in the progression of musculoskeletal and physical activity known as sarcopenia. ...
متن کاملWhy Age Matters: Inflammation, Cancer and Hormones in the Development of Sarcopenia
In an aging population, the decline in muscle mass and strength in combination with a high prevalence of osteoporosis and cancer leads to a multitude of clinical manifestations. In the recent years, mouse models of wasting in cancer and inflammation, including xenograft, genetic and chemically induced models, allowed to uncover several key mechanisms underlying muscle loss. These include inflam...
متن کاملCounteracting sarcopenia in post-menopausal women: do hormones and strength training accomplish the task?
Accelerated loss of muscle mass and strength with aging, termed sarcopenia, represents both an individual problem of decreased mobility as well as a socio-economic burden by increasing risk of falls and subsequent injuries, especially if combined with decreased bone density and mass. The causes of sarcopenia are multifactorial, and include: age-related decline in physical activity, anabolic ste...
متن کاملSarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).
1. Gerontopole Toulouse, Department of Geriatric Medicine, Toulouse University Hospital, Toulouse France, INSERM 1027; 2. Vice President, Clinical Research & Operations, Neuroscience & Neuromuscular Disorders, Cytokinetics, Inc. 280 East Grand Avenue, South San Francisco, CA 94080, USA; 3. Neurotune AG, Wagistr. 27A, 8952 Schlieren, Switzerland; 4. Senior Scientist and Director, Nutrition, Exer...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Opinion in Endocrine and Metabolic Research
سال: 2019
ISSN: 2451-9650
DOI: 10.1016/j.coemr.2019.06.006